India approves Gilead's remdesivir to treat severe COVID-19 cases

India approves Gilead's remdesivir to treat severe COVID-19 cases
Reuters: Health
India's government has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients.